| Product Code: ETC9975799 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sanger Sequencing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sanger Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sanger Sequencing Market - Industry Life Cycle |
3.4 United States (US) Sanger Sequencing Market - Porter's Five Forces |
3.5 United States (US) Sanger Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) Sanger Sequencing Market Revenues & Volume Share, By Sequencing, 2021 & 2031F |
3.7 United States (US) Sanger Sequencing Market Revenues & Volume Share, By Laboratory, 2021 & 2031F |
3.8 United States (US) Sanger Sequencing Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 United States (US) Sanger Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and genetic testing |
4.2.2 Technological advancements in sequencing techniques |
4.2.3 Rising prevalence of genetic disorders and chronic diseases |
4.3 Market Restraints |
4.3.1 High cost associated with sanger sequencing technology |
4.3.2 Competition from alternative sequencing technologies such as next-generation sequencing |
4.3.3 Regulatory challenges and ethical concerns related to genetic testing |
5 United States (US) Sanger Sequencing Market Trends |
6 United States (US) Sanger Sequencing Market, By Types |
6.1 United States (US) Sanger Sequencing Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sanger Sequencing Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) Sanger Sequencing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 United States (US) Sanger Sequencing Market Revenues & Volume, By Biomarkers and Cancer, 2021- 2031F |
6.1.5 United States (US) Sanger Sequencing Market Revenues & Volume, By Reproductive Health, 2021- 2031F |
6.1.6 United States (US) Sanger Sequencing Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.1.7 United States (US) Sanger Sequencing Market Revenues & Volume, By Forensics, 2021- 2031F |
6.1.8 United States (US) Sanger Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Sanger Sequencing Market, By Sequencing |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sanger Sequencing Market Revenues & Volume, By Shotgun Sequencing, 2021- 2031F |
6.2.3 United States (US) Sanger Sequencing Market Revenues & Volume, By Targeted Gene Sequencing, 2021- 2031F |
6.2.4 United States (US) Sanger Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Sanger Sequencing Market, By Laboratory |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Sanger Sequencing Market Revenues & Volume, By Wet Labs, 2021- 2031F |
6.3.3 United States (US) Sanger Sequencing Market Revenues & Volume, By Dry Labs, 2021- 2031F |
6.4 United States (US) Sanger Sequencing Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Sanger Sequencing Market Revenues & Volume, By Academic, 2021- 2031F |
6.4.3 United States (US) Sanger Sequencing Market Revenues & Volume, By Government Research Institutes, 2021- 2031F |
6.4.4 United States (US) Sanger Sequencing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.5 United States (US) Sanger Sequencing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.4.6 United States (US) Sanger Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.7 United States (US) Sanger Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United States (US) Sanger Sequencing Market Import-Export Trade Statistics |
7.1 United States (US) Sanger Sequencing Market Export to Major Countries |
7.2 United States (US) Sanger Sequencing Market Imports from Major Countries |
8 United States (US) Sanger Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for sequencing projects |
8.2 Rate of adoption of sanger sequencing in clinical diagnostics |
8.3 Number of research studies utilizing sanger sequencing technology |
9 United States (US) Sanger Sequencing Market - Opportunity Assessment |
9.1 United States (US) Sanger Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) Sanger Sequencing Market Opportunity Assessment, By Sequencing, 2021 & 2031F |
9.3 United States (US) Sanger Sequencing Market Opportunity Assessment, By Laboratory, 2021 & 2031F |
9.4 United States (US) Sanger Sequencing Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 United States (US) Sanger Sequencing Market - Competitive Landscape |
10.1 United States (US) Sanger Sequencing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sanger Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here